BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tell Proactive the group posted third-quarter results on Thursday that saw its revenue jump 60% year-over-year on the back of contributions from all four of its divisions including its subsidiary Clyra Medical Technologies. Clyra Medical Technologies President Steve Harrison adds that the group has successfully executed the first phase of the Clyraguard product launch, a personal disinfectant spray designed to decontaminate masks and other PPE, which is now available at www.clyramedical.com.
About this content
About
About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
No investment advice
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Content on the Site is provided for information purposes only, and none of the information contained on the Site constitutes an offer, solicitation or recommendation to buy or sell a security. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume which any Content on the Site may generate. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, suitability or profitability of any particular security, portfolio of securities, transaction, investment, investment strategy, or other matter. You understand...
FOR OUR FULL DISCLAIMER CLICK HEREBioLargo reveals 60% rise in 3Q revenue amidst roll-out of PPE disinfectant spray Clyraguard
Published: 16:41 09 Oct 2020 BST